This is, to our knowledge, the first study to report a predictive tumor-cell-associated protein biomarker for CNS relapse in early-stage NSCLC and the first study to report the correlation between NRF2 expression in CK+ cells and the risk of CNS relapse. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.